Q32 Bio Inc.
Income Statement
| Line Item | FY2018 | FY2017 |
|---|---|---|
| Revenue | $3.7M | — |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $47.9M | $21.4M |
| SG&A Expense | $17.3M | $8.3M |
| Operating Income | $-59.9M | $-29.7M |
| Operating Margin | -1,626.7% | — |
| Interest Expense | — | — |
| Pretax Income | — | — |
| Income Tax Expense | $0 | $0 |
| Net Income | $-55.6M | $-30.0M |
| Net Margin | -1,508.6% | — |
| EPS (Basic) | $-1.95 | $-12.10 |
| EPS (Diluted) | $-1.95 | $-12.10 |
| Shares Outstanding (Basic) | 37.4M | 2.6M |
| Shares Outstanding (Diluted) | 37.4M | 2.6M |
| Dividends Per Share | — | — |